Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.
about
B cells with regulatory properties in transplantation toleranceRegulatory T Cells in Kidney Transplantation: New Directions?Role of B cells in tolerance inductionTransplantation tolerance and its outcome during infections and inflammationRegulatory B cells: an exciting target for future therapeutics in transplantationRituximab in renal transplantationEffector mechanisms of rejectionFibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cellsReconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomesEffects of heme oxygenase-1 on innate and adaptive immune responses promoting pregnancy success and allograft toleranceThe involvement of SMILE/TMTC3 in endoplasmic reticulum stress responsePeripheral phenotype and gene expression profiles of combined liver-kidney transplant patients.Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.Alteration of naïve and memory B-cell subset in chronic graft-versus-host disease patients after treatment with mesenchymal stromal cells.Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis.A common gene signature across multiple studies relate biomarkers and functional regulation in tolerance to renal allograft.Diversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft model.Emergent Transcriptomic Technologies and Their Role in the Discovery of Biomarkers of Liver Transplant Tolerance.Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant.Central Role of CD45RA- Foxp3hi Memory Regulatory T Cells in Clinical Kidney Transplantation ToleranceTolerance signatures in transplant recipientsDonor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipientsTolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.A new paradigm for an old story: the role of regulatory B cells in cancerPreserving the B-cell compartment favors operational tolerance in human renal transplantation.Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study.Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipientsThe paradoxical functions of B cells and antibodies in transplantationB Cells with Regulatory Function in Human DiseasesChimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantationReconsidering the bio-detection of tolerance in renal transplantation.Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized studyRegulatory B cells and tolerance in transplantation: from animal models to human.Increased CD40 Ligation and Reduced BCR Signalling Leads to Higher IL-10 Production in B Cells From Tolerant Kidney Transplant Patients.B10 Cell Frequencies and Suppressive Capacity in Myasthenia Gravis Are Associated with Disease Severity.Old game, new players: Linking classical theories to new trends in transplant immunology.Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.Clinical transplantation tolerance.Microchimerism in promoting graft acceptance in clinical transplantation.Targeting B cells and antibody in transplantation
P2860
Q26771404-DA538F86-ECE7-4609-9B4E-EF2E9E44CF80Q26800184-B83958F6-9246-4C23-B7C5-417AC121DFE8Q26824451-6B3883E2-1271-40AF-903B-8E6620E8A0CEQ26829817-E72F8318-6831-4B3F-B58D-16F431842203Q27015093-45D73E6E-B292-4DD4-B77B-5DBB3713B22FQ27026434-3BF74EEF-CA5C-4B26-B5EA-176468F5DBB8Q27027082-87D288D1-10EF-4FB5-A873-1F69A1D5F996Q27311751-2A32E381-491C-46EA-AC4D-24546CAA0D43Q28080994-16C3CD97-2758-4563-98EB-ED010DCC13F8Q28084287-A0C11AC5-2734-4A62-A467-D3EE6BE4B708Q28478144-B6B1230E-D719-41BB-9F52-A74BD0C7FEF1Q33574118-1FB955FB-6F50-4F15-A639-02C634F3686FQ33766714-92F3965C-92AF-4FD4-96DF-E92FA37A5CD6Q34109382-E43155C8-1100-4D55-B920-9FD76421D8F4Q35541507-5D91E0CB-ED28-4B64-8681-6A24A8FE7CDCQ35584849-26050D4E-6CFC-4625-8D48-A701CA517BD7Q35673671-5CDFACD5-3800-4A80-A761-F919BDC11556Q35765609-CA4946E6-E811-4937-AC67-1B25D91D4CE0Q35853304-0F687727-25D1-4E24-A38E-BC3120DF44C4Q35903107-2824CA64-A368-47C9-9F23-CDFAF9777995Q35915308-6B0DD0DD-7951-4696-B0E7-9A75F14628CFQ36030401-C1E7E57C-B211-4856-9A25-137A341A6587Q36104784-AD8D24A0-51B1-4D9E-AD59-A757E43F42A3Q36107944-99B75422-6C7F-4563-AD4D-760DF67838C2Q36130967-684440B8-A41E-452C-BF29-A3D1126E2F44Q36425407-183EFEE6-B440-42A7-A3EF-5402D475FAE9Q36498594-20A37B9F-F08D-4BF5-B002-0663F36E77D7Q36563918-F9105003-0909-4C5D-83D8-345695EF04ACQ36677543-69ED28F0-FE9A-4FFF-9660-A1D759416FE5Q36722979-C7F30C78-0298-4569-B693-76BA4AD31539Q36846202-38595780-1C71-4BA4-B3F5-0D785674018FQ37022116-A45CA3A5-8C7A-4714-9B7F-1CBF7C0A758FQ37420774-5B721555-F95F-4C8D-9997-64E8FB3CA51DQ37527388-B07EEB99-8E28-4467-8043-CF4A619A23B5Q37634710-B0B746AF-2EA1-4F17-AA49-7C97B34C7F67Q37662989-052D2AF7-FFFD-45CA-9F84-4ACF13D4A722Q37715369-D3FEF9B5-A25C-4F5D-B9E3-A8B0BC8F299CQ37843801-E1A32C29-5843-4390-9237-7A42EEA01649Q37888423-44746ED3-F8F0-4BEE-BE0F-82792D82DCE1Q37888770-F522BB2C-0E0E-42D2-9E7A-1959919F584D
P2860
Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Patients with drug-free long-t ...... mory and inhibitory phenotype.
@en
Patients with drug-free long-t ...... mory and inhibitory phenotype.
@nl
type
label
Patients with drug-free long-t ...... mory and inhibitory phenotype.
@en
Patients with drug-free long-t ...... mory and inhibitory phenotype.
@nl
prefLabel
Patients with drug-free long-t ...... mory and inhibitory phenotype.
@en
Patients with drug-free long-t ...... mory and inhibitory phenotype.
@nl
P2093
P50
P356
P1433
P1476
Patients with drug-free long-t ...... mory and inhibitory phenotype.
@en
P2093
Annaick Pallier
Anne Cesbron-Gautier
Anne Devys
Catherine Larrose
Cécile Braudeau
Emilie Dugast
Joanna Ashton-Chess
Juan José Lozano
Magali Giral
Maud Racapé
P2888
P304
P356
10.1038/KI.2010.162
P407
P577
2010-06-09T00:00:00Z